Dechra Pharmaceuticals (LSE: DPH) has acquired Med-Pharmex Inc. Med-Pharmex is a leading veterinary pharmaceutical manufacturer based in Pomona, California. The total consideration paid was US$260.0 million on a debt-free and cash-free basis and was subject to normal closing adjustments.
Source: NewsnReleases, August 30, 2022. Link.
I am delighted that we have completed the acquisition of Med-Pharmex, a company that I have been in dialogue with for a number of years. The US market is highly consolidated therefore this is a unique opportunity to add several new products to our portfolio, enter the US FAP market and improve the manufacturing footprint for our North American business.” – Ian Page, CEO